Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1965 1
1967 1
1970 1
1971 3
1972 2
1973 3
1974 3
1975 2
1976 3
1977 5
1978 5
1979 6
1980 9
1981 2
1982 5
1983 9
1984 6
1985 10
1986 8
1987 3
1988 16
1989 9
1990 7
1991 16
1992 23
1993 26
1994 26
1995 14
1996 18
1997 23
1998 25
1999 17
2000 19
2001 21
2002 34
2003 42
2004 48
2005 49
2006 68
2007 97
2008 77
2009 118
2010 133
2011 133
2012 132
2013 145
2014 149
2015 152
2016 152
2017 152
2018 152
2019 149
2020 146
2021 191
2022 198
2023 156
2024 150

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,867 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A, Guttman-Yassky E, Paller AS, Simpson EL, Cork MJ, Weisman J, Browning J, Soong W, Sun X, Chen Z, Kosloski MP, Kamal MA, Delevry D, Chuang CC, O'Malley JT, Bansal A. Blauvelt A, et al. Among authors: chuang cc. Am J Clin Dermatol. 2022 May;23(3):365-383. doi: 10.1007/s40257-022-00683-2. Epub 2022 May 14. Am J Clin Dermatol. 2022. PMID: 35567671 Free PMC article. Clinical Trial.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball AB, Delevry D, Yang M, Chuang CC, Wang Z, Bégo-Le-Bagousse G, Martins B, Wu E, Shumel B, Wang J, Sierka D, Chao J, Strober B. Kimball AB, et al. Among authors: chuang cc. Dermatol Ther (Heidelb). 2023 Sep;13(9):2107-2120. doi: 10.1007/s13555-023-00965-5. Epub 2023 Aug 8. Dermatol Ther (Heidelb). 2023. PMID: 37552431 Free PMC article.
Managing Undesired Pregnancy After Dobbs.
Casas RS, Horvath SK, Schwarz EB, Bachorik AE, Chuang CC. Casas RS, et al. Among authors: chuang cc. J Gen Intern Med. 2022 Dec;37(16):4272-4275. doi: 10.1007/s11606-022-07833-6. Epub 2022 Oct 11. J Gen Intern Med. 2022. PMID: 36220947 Free PMC article.
FAK in Cancer: From Mechanisms to Therapeutic Strategies.
Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS, Yang CJ. Chuang HH, et al. Among authors: chuang ch. Int J Mol Sci. 2022 Feb 2;23(3):1726. doi: 10.3390/ijms23031726. Int J Mol Sci. 2022. PMID: 35163650 Free PMC article. Review.
Pulmonary alveolar proteinosis in Taiwan.
Chuang CH, Cheng CH, Tsai YC, Tsai MJ, Sheu CC, Chong IW. Chuang CH, et al. J Formos Med Assoc. 2023 Oct;122(10):1061-1068. doi: 10.1016/j.jfma.2023.04.002. Epub 2023 Apr 25. J Formos Med Assoc. 2023. PMID: 37105870 Free article.
2,867 results